Pharmaceutical innovation has accelerated, but the way of dosing oral medic...

Originally developed for and tested on a number of common cancers, the drug...

In the current climate there are several major challenges or trends in inve...

Now in its third year, the LSX Investor Perception Survey 2019 tracks the v...

Around two thirds (61%) of life science investor respondents look for manag...

As new technologies look to play an ever-increasing role in addressing heal...

On 25 October 2018 the Court of Justice of the European Union (CJEU) handed...

On 5 February 2019, a panel of leading medtech investors will open the 5th ...

In October 2018, German medical device company Protembis closed an oversubs...

On 5-6 February 2019, international life sciences investors, C-level execut...

Senior executives and investors in the life sciences sector will convene in...

Key learnings: Oxford-based Oxehealth has secured medical device accreditat...